Vaxxinity Formerly Known as Covaxx
medical manufacturing
Based in TX
AI Overview
With $430K in lobbying spend across 6 quarterly filings, Vaxxinity Formerly Known as Covaxx is an active lobbying client. Their lobbying covers 1 issue area.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $430K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Vaxxinity Formerly Known as Covaxx disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
issues relating to vaccine development and expediting Emergency Use Authorization
issues relating to vaccine development, expedite FDA Emergency Use Authorization
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.